PDS Biotech Receives $1.4 Million After Selling Its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Program
April 24, 2023 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 24, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Elevar Therapeutics Presents AACR 2023 Poster Demonstrating Rivoceranib as Most Selective VEGFR-2 Inhibitor When Compared to Other TKIs With Known Activity Against VEGFR-2
April 18, 2023 09:00 ET
|
Elevar Therapeutics
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
As a Breast Cancer Survivor, I've Seen Firsthand How Early Detection and Clinical Trial Initiatives Save Lives
April 14, 2023 09:47 ET
|
National Women's Health Network
Washington D.C., April 14, 2023 (GLOBE NEWSWIRE) -- Diagnosed By Chance As the former Executive Director of the American Cancer Society, I can confidently say I’m cancer-literate. I get mammograms...
PDS Biotech to Host Interleukin 12 (IL-12) Immunocytokine-Focused KOL Roundtable on April 21, 2023
April 12, 2023 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference
April 11, 2023 08:30 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced details relating to eight...
Global Interventional Oncology Devices Market Report 2023: Players Include Boston Scientific, Medtronic, Terumo, and Philips Volcano
March 30, 2023 10:18 ET
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Amplified Sciences, Inc. revolutionizing early-detection diagnostics of pancreatic cancer and other diseases
March 14, 2023 08:00 ET
|
Purdue Research Foundation
WEST LAFAYETTE, INDIANA, March 14, 2023 (GLOBE NEWSWIRE) -- A series of early-detection diagnostic tests under development by a Purdue-sponsored startup may commute the death sentence often...
United in the Fight Against Colorectal Cancer
March 01, 2023 17:42 ET
|
Fight Colorectal Cancer
Springfield, Mo., March 01, 2023 (GLOBE NEWSWIRE) -- On the heels of the White House declaring March as Colorectal Cancer Awareness Month, urging the public to get screened, national advocacy...
Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
February 10, 2023 07:35 ET
|
Sunshine Biopharma Inc.
MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium
January 25, 2023 07:00 ET
|
Theralase Technologies Inc.
TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...